There were 140 press releases posted in the last 24 hours and 425,927 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
SeraNovo Enters into a Second License Agreement with Carna Biosciences for Development of Oral Formulation of Carna’s Kinase Inhibitor

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image